Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy C Jones

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
The Oncologist|December 8, 2025
Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decadesFares Jamal, Oudai Sahvan, Pedro Luiz Serrano Uson Junior, et al.
Clinical Colorectal Cancer|October 12, 2016
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal CancerBen Y Zhang, Jeremy C Jones, Andrew M Briggler, et al.
Cancers|May 27, 2026
Circulating Biomarkers in Localized Anal Squamous Cell Carcinoma Across Treatment Timepoints: A Systematic ReviewOluwatayo Adeoye, Abdulsabur Sanni, Khujasta Gul, et al.
The Journal of Infectious Diseases|September 28, 2023
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023Konstantin Andreev, Jeremy C Jones, Patrick Seiler, et al.
Journal of Virology|March 7, 2022
Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in FerretsMeng Hu, Jeremy C Jones, Balaji Banoth, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant VariantsPhilippe Noriel Q Pascua, Jeremy C Jones, Bindumadhav M Marathe, et al.
Antiviral Research|November 5, 2017
A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatmentBindumadhav M Marathe, Heba H Mostafa, Peter Vogel, et al.
Science Advances|March 29, 2023
Hemagglutinin destabilization in H3N2 vaccine reference viruses skews antigenicity and prevents airborne transmission in ferretsMeng Hu, Christina Kackos, Balaji Banoth, et al.
Journal of Virology|November 15, 2013
Risk assessment of H2N2 influenza viruses from the avian reservoirJeremy C Jones, Tatiana Baranovich, Bindumadhav M Marathe, et al.
Plos Pathogens|July 13, 2022
Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmissionJeremy C Jones, Bogdan Zagribelnyy, Philippe Noriel Q Pascua, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
The Oncologist|December 8, 2025
Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decadesFares Jamal, Oudai Sahvan, Pedro Luiz Serrano Uson Junior, et al.
Clinical Colorectal Cancer|October 12, 2016
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal CancerBen Y Zhang, Jeremy C Jones, Andrew M Briggler, et al.
Cancers|May 27, 2026
Circulating Biomarkers in Localized Anal Squamous Cell Carcinoma Across Treatment Timepoints: A Systematic ReviewOluwatayo Adeoye, Abdulsabur Sanni, Khujasta Gul, et al.
The Journal of Infectious Diseases|September 28, 2023
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023Konstantin Andreev, Jeremy C Jones, Patrick Seiler, et al.
Journal of Virology|March 7, 2022
Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in FerretsMeng Hu, Jeremy C Jones, Balaji Banoth, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant VariantsPhilippe Noriel Q Pascua, Jeremy C Jones, Bindumadhav M Marathe, et al.
Antiviral Research|November 5, 2017
A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatmentBindumadhav M Marathe, Heba H Mostafa, Peter Vogel, et al.
Science Advances|March 29, 2023
Hemagglutinin destabilization in H3N2 vaccine reference viruses skews antigenicity and prevents airborne transmission in ferretsMeng Hu, Christina Kackos, Balaji Banoth, et al.
Journal of Virology|November 15, 2013
Risk assessment of H2N2 influenza viruses from the avian reservoirJeremy C Jones, Tatiana Baranovich, Bindumadhav M Marathe, et al.
Plos Pathogens|July 13, 2022
Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmissionJeremy C Jones, Bogdan Zagribelnyy, Philippe Noriel Q Pascua, et al.
Pageof 8